User menu

The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers.

  1. Yu Mikyung, Wu Jun, Shi Jinjun, Farokhzad Omid C., Nanotechnology for protein delivery: Overview and perspectives, 10.1016/j.jconrel.2015.10.012
  2. Parveen Suphiya, Misra Ranjita, Sahoo Sanjeeb K., Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging, 10.1016/j.nano.2011.05.016
  3. Araújo Francisca, Shrestha Neha, Granja Pedro L, Hirvonen Jouni, Santos Hélder A, Sarmento Bruno, Safety and toxicity concerns of orally delivered nanoparticles as drug carriers, 10.1517/17425255.2015.992781
  4. Aguirre T.A.S., Teijeiro-Osorio D., Rosa M., Coulter I.S., Alonso M.J., Brayden D.J., Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials, 10.1016/j.addr.2016.02.004
  5. Shan Wei, Zhu Xi, Liu Min, Li Lian, Zhong Jiaju, Sun Wei, Zhang Zhirong, Huang Yuan, Overcoming the Diffusion Barrier of Mucus and Absorption Barrier of Epithelium by Self-Assembled Nanoparticles for Oral Delivery of Insulin, 10.1021/acsnano.5b00028
  6. Lopes Marlene, Shrestha Neha, Correia Alexandra, Shahbazi Mohammad-Ali, Sarmento Bruno, Hirvonen Jouni, Veiga Francisco, Seiça Raquel, Ribeiro António, Santos Hélder A., Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin, 10.1016/j.jconrel.2016.04.012
  7. Niu Zhigao, Tedesco Erik, Benetti Federico, Mabondzo Aloïse, Montagner Isabella Monia, Marigo Ilaria, Gonzalez-Touceda David, Tovar Sulay, Diéguez Carlos, Santander-Ortega Manuel J., Alonso María J., Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers, 10.1016/j.jconrel.2017.02.024
  8. Niu Zhigao, Conejos-Sánchez Inmaculada, Griffin Brendan T., O’Driscoll Caitriona M., Alonso María J., Lipid-based nanocarriers for oral peptide delivery, 10.1016/j.addr.2016.04.001
  9. Shrestha Neha, Shahbazi Mohammad-Ali, Araújo Francisca, Mäkilä Ermei, Raula Janne, Kauppinen Esko I., Salonen Jarno, Sarmento Bruno, Hirvonen Jouni, Santos Hélder A., Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: A controlled dual protein-drug delivery system, 10.1016/j.biomaterials.2015.07.045
  10. Shrestha Neha, Shahbazi Mohammad-Ali, Araújo Francisca, Zhang Hongbo, Mäkilä Ermei M., Kauppila Jussi, Sarmento Bruno, Salonen Jarno J., Hirvonen Jouni T., Santos Hélder A., Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers, 10.1016/j.biomaterials.2014.04.104
  11. Park Kyeongsoon, Kwon Ick Chan, Park Kinam, Oral protein delivery: Current status and future prospect, 10.1016/j.reactfunctpolym.2010.10.002
  12. Oh Da Young, Lagakos William S, The role of G-protein-coupled receptors in mediating the effect of fatty acids on inflammation and insulin sensitivity : , 10.1097/mco.0b013e3283479230
  13. HOLST J, VILSBOLL T, DEACON C, The incretin system and its role in type 2 diabetes mellitus, 10.1016/j.mce.2008.08.012
  14. Holst Jens Juul, Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery, 10.1016/j.coph.2013.09.014
  15. Moran Gordon W., Leslie Fiona C., Levison Scott E., McLaughlin John T., Review: Enteroendocrine cells: Neglected players in gastrointestinal disorders?, 10.1177/1756283x08093943
  16. Beloqui Ana, Alhouayek Mireille, Carradori Dario, Vanvarenberg Kevin, Muccioli Giulio G., Cani Patrice D., Préat Véronique, A Mechanistic Study on Nanoparticle-Mediated Glucagon-Like Peptide-1 (GLP-1) Secretion from Enteroendocrine L Cells, 10.1021/acs.molpharmaceut.6b00871
  17. Lovshin Julie A., Drucker Daniel J., Incretin-based therapies for type 2 diabetes mellitus, 10.1038/nrendo.2009.48
  18. Thorens B., Porret A., Buhler L., Deng S.-P., Morel P., Widmann C., Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9-39) an Antagonist of the Receptor, 10.2337/diab.42.11.1678
  19. Elbrond B., Jakobsen G., Larsen S., Agerso H., Jensen L. B., Rolan P., Sturis J., Hatorp V., Zdravkovic M., Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of a Single-Dose of NN2211, a Long-Acting Glucagon-Like Peptide 1 Derivative, in Healthy Male Subjects, 10.2337/diacare.25.8.1398
  20. Beloqui Ana, Coco Régis, Alhouayek Mireille, Solinís María Ángeles, Rodríguez-Gascón Alicia, Muccioli Giulio G., Préat Véronique, Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis, 10.1016/j.ijpharm.2013.05.017
  21. Gartziandia Oihane, Egusquiaguirre Susana Patricia, Bianco John, Pedraz José Luis, Igartua Manoli, Hernandez Rosa Maria, Préat Véronique, Beloqui Ana, Nanoparticle transport across in vitro olfactory cell monolayers, 10.1016/j.ijpharm.2015.12.046
  22. Keita Åsa V, Gullberg Elisabet, Ericson Ann-Charlott, Salim Sa'ad Y, Wallon Conny, Kald Anders, Artursson Per, Söderholm Johan D, Characterization of antigen and bacterial transport in the follicle-associated epithelium of human ileum, 10.1038/labinvest.3700397
  23. Hubatsch Ina, Ragnarsson Eva G E, Artursson Per, Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers, 10.1038/nprot.2007.303
  24. Wiśniewski Jacek R., Gaugaz Fabienne Z., Fast and Sensitive Total Protein and Peptide Assays for Proteomic Analysis, 10.1021/ac504689z
  25. Hotze Ernest M., Phenrat Tanapon, Lowry Gregory V., Nanoparticle Aggregation: Challenges to Understanding Transport and Reactivity in the Environment, 10.2134/jeq2009.0462
  26. Meier Juris J., GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus, 10.1038/nrendo.2012.140
  27. Araújo Francisca, Shrestha Neha, Shahbazi Mohammad-Ali, Liu Dongfei, Herranz-Blanco Bárbara, Mäkilä Ermei M., Salonen Jarno J., Hirvonen Jouni T., Granja Pedro L., Sarmento Bruno, Santos Hélder A., Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs, 10.1021/acsnano.5b02762
  28. Beloqui Ana, Solinís María Ángeles, Delgado Araceli, Évora Carmen, Isla Arantxazu, Rodríguez-Gascón Alicia, Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution, 10.3109/02652048.2013.788090
  29. Beloqui Ana, Solins Mara ngeles, Gascn Alicia R., del Pozo-Rodrguez Ana, des Rieux Anne, Prat Vronique, Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier, 10.1016/j.jconrel.2012.12.021
  30. Klein Sandra, The Use of Biorelevant Dissolution Media to Forecast the In Vivo Performance of a Drug, 10.1208/s12248-010-9203-3
  31. Shrestha Neha, Araújo Francisca, Shahbazi Mohammad-Ali, Mäkilä Ermei, Gomes Maria João, Herranz-Blanco Bárbara, Lindgren Rici, Granroth Sari, Kukk Edwin, Salonen Jarno, Hirvonen Jouni, Sarmento Bruno, Santos Hélder A., Thiolation and Cell-Penetrating Peptide Surface Functionalization of Porous Silicon Nanoparticles for Oral Delivery of Insulin, 10.1002/adfm.201505252
  32. Kuhre Rune Ehrenreich, Wewer Albrechtsen Nicolai Jacob, Deacon Carolyn Fiona, Balk-Møller Emilie, Rehfeld Jens Frederik, Reimann Frank, Gribble Fiona Mary, Holst Jens Juul, Peptide production and secretion in GLUTag, NCI-H716, and STC-1 cells: a comparison to native L-cells, 10.1530/jme-15-0293
  33. Araújo Francisca, Sarmento Bruno, Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies, 10.1016/j.ijpharm.2013.10.003
  34. Artursson Per, Palm Katrin, Luthman Kristina, Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1, 10.1016/s0169-409x(00)00128-9
  35. Gerloff Kirsten, Pereira Dora I.A., Faria Nuno, Boots Agnes W., Kolling Julia, Förster Irmgard, Albrecht Catrin, Powell Jonathan J., Schins Roel P.F., Influence of simulated gastrointestinal conditions on particle-induced cytotoxicity and interleukin-8 regulation in differentiated and undifferentiated Caco-2 cells, 10.3109/17435390.2012.662249
  36. Brubaker P. L., Schloos J., Drucker D. J., Regulation of Glucagon-Like Peptide-1 Synthesis and Secretion in the GLUTag Enteroendocrine Cell Line1, 10.1210/endo.139.10.6228
  37. Reimann F., Ward P. S., Gribble F. M., Signaling Mechanisms Underlying the Release of Glucagon-Like Peptide 1, 10.2337/db06-s010
  38. Marathe Chinmay S., Rayner Christopher K., Jones Karen L., Horowitz Michael, Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function, 10.1155/2011/279530
  39. Lundquist P., Artursson P., Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues, 10.1016/j.addr.2016.07.007
  40. Hilgendorf Constanze, Spahn‐Langguth Hildegard, Regårdh Carl G., Lipka Elke, Amidon Gordon L., Langguth Peter, Caco‐2 versus Caco‐2/HT29‐MTX Co‐cultured Cell Lines: Permeabilities Via Diffusion, Inside‐ and Outside‐Directed Carrier‐Mediated Transport, 10.1002/(sici)1520-6017(200001)89:1<63::aid-jps7>;2-6
  41. Ensign L. M., Tang B. C., Wang Y.-Y., Tse T. A., Hoen T., Cone R., Hanes J., Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus, 10.1126/scitranslmed.3003453
  42. Beloqui Ana, Solinís María Ángeles, Rieux Anne des, Préat Véronique, Rodríguez-Gascón Alicia, Dextran–protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs, 10.1016/j.ijpharm.2014.04.027
  43. Yu Tao, Wang Ying-Ying, Yang Ming, Schneider Craig, Zhong Weixi, Pulicare Sarah, Choi Woo-Jin, Mert Olcay, Fu Jie, Lai Samuel K., Hanes Justin, Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-co-glycolic acid), 10.1007/s13346-011-0048-9
Bibliographic reference Shrestha, Neha ; Bouttefeux, Oriane ; Vanvarenberg, Kevin ; Lundquist, Patrik ; Cunarro, Juan ; et. al. The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers.. In: Nanoscale, Vol. 10, p. 603-613 (2018)
Permanent URL